TPM3 and cancer: TRK activation due to such fusions promotes the development of cancer by promoting cancer cell survival or proliferation through the activation of phosphoinositide 3‐kinase–AKT, mitogen‐activated protein kinase, and phospholipase C pathways.3, 5